Monthly Archives: January 2017

Cencosud S.A. Announces Guidance for 2017

– For 2017 The Company Expects a Progressive Acceleration of Revenue Growth, Reaching USD 16,500Million in The Year, Due to a Better Performance from the Businesses, Increased Online Business Growth, Selected Store Openings and an Improved Economic Regional Environment, Particularly in Peru, Argentina, and Brazil;
– Continuing with the Implemented Financial Strengthening and Profitability Plan, it Would Take Adjusted EBITDA to an Expected Range of 7.3% to 7.6%;
– Capex Plan Reaches USD 500 Million for 2017 and it is Estimated at USD 2,500 Million for the Next 4 Years

SANTIAGO, CHILE / ACCESSWIRE /January 30, 2017 / Cencosud S.A. (NYSE: CNCO, SSE: CENCOSUD), informs about its expectations and investment plan (“Guidance”) for 2017:

Prospects for 2017

Cencosud will continue to deepen its Financial Strengthening and Business Profitability Plan, progressively accelerating sales growth, as a result of the reinforcement of its Value Proposition, online business and organic growth on markets of greatest potential. The aforementioned is also supported by greater maturity reached among the countries with operations, having reached a solid financial position, and the prospect of a more favorable regional economic context, particularly in Peru, Argentina, and Brazil.

Consolidated Revenues are expected to reach the equivalent to USD 16,500 million1 in the year (which will depend on currency fluctuations), and an Adjusted EBITDA in the range of 7.3% to 7.6%.

The Company will continue to advance on defined strategic pillars:

1. Reinforcement of its Value Proposition, shopping experience and Customer loyalty

The Plan to reinforce the Value Proposition and store competitiveness considers an increased pace on store remodeling, along with the standardization of operational processes and improved logistic capabilities.

A strategic impulse will be given to CRM and Customer Loyalty, through the implementation of a world class Customer Centricity Platform. This new SAP HANA tool – which first step will be in Chile – will provide a consolidated customer view through all formats and channels, allowing to manage and optimize online commercial, marketing and planning initiatives, generating sales and margin expansions.

2. Omnichannel developments, Innovation and leadership in new trends

Supermarkets: a new e-commerce platform will be implemented for Chile, Colombia, Argentina and Peru, to obtain synergies at the development and support for websites at food and greater demand adjustment capabilities. In Chile, Click & Collect and Drive thru availability will be expanded to all regional capitals, Self-Check Out will be implemented at 13 Jumbo stores and Self Scanning at 43 Santa Isabel stores, besides the 100% migration to a new check-out technology system. In Argentina, e-commerce coverage will be expanded to 100% of the cities where the brand has a store and Drive thru will be placed at 10 Disco and Jumbo stores. In Peru, Click & Collect will be executed at 4 locations and Drive thru at 2 stores; virtual kiosks will be offered at all non-food purchases and the web service for online purchases will be launched at Metro. In Colombia, 100% coverage of telephone sales will be achieved in cities where it has a store, Jumbo’s e-commerce and Drive thru coverage will be expanded to Bogota, Medellin and Cali, Click & Collect to Bogotá, and will begin food e-commerce sales at Metro.

Department Stores: a new e-commerce website will be launched in Chile, to potentiate the visits conversion rate thru increased assortment and fewer steps to complete payment, allowing to optimize logistic operations and back-office. Green sales will be offered; resulting from technological integration with suppliers, which will permit us to offer greater assortment with lower inventories. In Peru, e-commerce operations will be inaugurated and a relevant step will be taken towards the widening of online assortment of products.

Home Improvement: WMS will begin to operate (Warehouse Management Software) at Easy Distribution Center in Chile, for the automation of orders; Green Sales will be potentiated and automated, Click & Collect service provided and a special module for sales to corporations will be implemented at Chile’s website.

Shopping Centers: Wi-Fi service will be amplified at all of our main Shopping Centers, as well as mobile app developments.

Focus on Health & Wellness, environmental care, private label and exclusive brands penetration, and the implementation of Sustainability and CSR programs will be deepened in all the region.

3. Efficiency, productivity and financial discipline

We will continued to work on the review of underperforming stores and the search of efficiencies thru the consolidation of commercial and non-commercial purchase agreements (services, supplies, equipment, etc.) and over the optimization and automation of back-office services managed by the Shared Service Center.

At logistics, the construction of a new Distribution Center for Easy will be initiated in Argentina, and the installation of an automatic sorter at Buenos Aires Distribution Center. At Department Stores, CD’s mechanization will be widened. In Colombia, the strengthening of perishables distribution network is foreseen at country level, and in Peru, an upgrade of ERP SAP platform will be implemented.

In Brazil, changes in processes are expected to secure levels of availability of products above 90%, the automation of the product registration system in SAP (Cadastro) will be completed and wifi collectors will be implemented to receive products in store. Cencosud will continue with the Plan of sale of non-core assets and businesses and evaluating alternatives that will accelerate the development of the real estate potential across the Region.

Although the company has a solid level of liquidity and a comfortable maturity profile, financial discipline will continue to focus on gradually strengthening of financial and debt indicators.

2 Figures as of September 30, 2016 pro-forma post local bond issuance. Gross debt amortization, net from mark to market derivatives associated to each of the liabilities.

Investment Plan

During 2016, 15 new stores were opened: 12 Supermarkets, 2 Department Stores and 1 Home Improvement Store. In addition, a new Perishable Distribution Center was inaugurated in Chile, the construction of 2 Shopping Centers was started; One in La Molina, Peru and another in Valdivia, Chile and the extension of the Restaurants Boulevard in Alto Las Condes. In parallel, 38 remodeling projects were developed – distributed in the 5 countries – 27 of which were completed within the year.

By 2017, the focus of investments will continue to be on strengthening of the Value Proposition and competitiveness of stores, innovation and improvement in logistics and technological capabilities, Omnichannel development and growth in sales area through selective opening of stores and the acceleration of remodeling Plan. In addition to the above, will start the development of new Shopping Centers in the Region and expansion of existing malls.

Organic growth for the next 4 years includes investments of USD 2.5 billion, while 2017 Capex is estimated at USD 500 million, which will be financed mainly by the generation of own resources.

Contact Information

Marisol Fernandez
Investor Relations Officer
Tel +562 2959 0545
mariasoledad.fernandez@cencosud.cl

Natalia Nacif
Senior IR Analyst
Tel +562 2959 0368
natalia.nacif@cencosud.cl

Valentina Klein
IR Analyst
Tel +562 2200 4395
valentina.klein@cencosud.cl

Disclaimer

The statements contained in this release regarding the business outlook of the Company, projections of operating / financial results, the growth potential of the company and market and macroeconomic estimates are mere forecasts and are based on management’s expectations regarding the future of the Company. These expectations are highly dependent on market changes, the general economic performance of Latin America and in particular the countries where we operate, industry and international markets, and are therefore subject to change.

FOOTNOTES:

1Considers the following average Exchange rates against USD for 2017:

SOURCE: Cencosud S.A.

ReleaseID: 453855

Uterine Fibroids Pharmaceutical and Healthcare Pipeline Review H2

WiseGuyReports.com adds “Uterine Leiomyoma (Uterine Fibroids) Global Clinical Trials Review, H2, 2016” reports to its database.

Pune, India – January 30, 2017 /MarketersMedia/

Summary
“Uterine Leiomyoma (Uterine Fibroids) Global Clinical Trials Review, H2, 2016″ provides an overview of Uterine Leiomyoma (Uterine Fibroids) clinical trials scenario. This report provides top line data relating to the clinical trials on Uterine Leiomyoma (Uterine Fibroids). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical Trial Reports are generated using proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/910185-uterine-leiomyoma-uterine-fibroids-global-clinical-trials-review-h2-2016

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Scope
– The report provides a snapshot of the global clinical trials landscape
– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
– The Report provides enrollment trends for the past five years
– Report provides latest news for the past three months

Reasons to buy
– Assists in formulating key business strategies with regards to investment
– Helps in identifying prominent locations for conducting clinical trials which saves time and cost
– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
– Supports understanding of trials count and enrollment trends by country in global therapeutics market
– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
– Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Content: Key Points
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Uterine Leiomyoma (Uterine Fibroids) to Non Malignant Disorders Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Uterine Leiomyoma (Uterine Fibroids) to Non Malignant Disorders Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Uterine Leiomyoma (Uterine Fibroids) Therapeutics Clinical Trials 27
Prominent Drugs 29
Latest Clinical Trials News on Uterine Leiomyoma (Uterine Fibroids) 30
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/910185-uterine-leiomyoma-uterine-fibroids-global-clinical-trials-review-h2-2016

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Contact Info:
Name: Norah Trent
Organization: WiseGuy Reports
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune – 411028 Maharashtra, India
Phone: +1-646-845-9349

Source URL: http://marketersmedia.com/uterine-fibroids-pharmaceutical-and-healthcare-pipeline-review-h2/165396

For more information, please visit http://www.wiseguyreports.com

Source: MarketersMedia

Release ID: 165396

Lysine Market 2017 Global Analysis, Opportunities and Forecast to 2021

Lysine -Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2021

Pune, India – January 30, 2017 /MarketersMedia/

Lysine Industry

Description

Wiseguyreports.Com Adds “Lysine -Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2021” To Its Research Database

This report on Lysine gives a market insight into various applications of Lysine in Feed Additives, Food & Dietary Supplements, Pharmaceuticals and Other segments. The report serves as a guide to the global Lysine industry, covering more than 400 companies that are engaged in production and processing of raw material or end use product.

Information related to recent product releases, product developments, partnerships, collaborations, and mergers and acquisitions is covered in the report. Compilation of Worldwide Patents related to Lysine is also provided. A global perspective is presented along with regional analysis covering the regions of North America, Europe, China, Asia-Pacific, and Rest of World with 121 exclusive graphically represented exhibits.

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/905737-lysine-market-research-report

Highlights

Global Lysine market is projected to grow at 9.5% annually through 2010 – 2022. Today amino acids can be taken as a supplement that is available commercially. Amino acid supplements are usually made from animal protein, vegetable protein, or yeast. While almost all amino acids can be produced in two forms, L and D form. There has been a substantial increase in the demand for amino acids in the last thirty years or so. There is a steady 5-10% growth rate in the market. It is estimated that in that last ten years the market demand for amino acids has doubled.

L-lysine, which is used as an additive in animal feed, has shown a sharp increase in demand. It is estimated that the global market for L-lysine has increased almost 20 times in the past twenty years. Among the amino acids available in the market, L-Glutamate is still the most popular one followed by L-lysine and D, L-methionine. The prices of amino acids are often affected by the dynamics in the market. The increase in the efficiency of the fermentation technology can lead to the development of cheaper goods and thereby increase the overall demand. Subsequently, there is bound to be large-scale production of these products which will lower the costs even more.

However, despite these trends in the market, the supply of amino acids such as L-lysine to be used as feed additives will compete with soybean meal which is a natural source of L-lysine. Amino acids continue to command a large market share, and continue to grow. The packaged food industry is now becoming the major user of amino acids, and the demand from society remains strong for such food supplements. Amino acids are now being used in many forms including health-food drinks, body building supplements, and even nutrients in the intravenous feeding and maintenance products.

Exclusive 25 % flat discount (Offer valid till 31st March 2017) @ https://www.wiseguyreports.com/enquiry/905737-lysine-market-research-report

Key Players

Ajinomoto Co., Inc. (Japan)

Archer Daniels Midland Co. (USA)

CJ Cheil Jedang (South Korea)

Global Bio-Chem Tech Group Co., Ltd. (China)

Ningxia EPPEN Biotech Co., Ltd. (China)

A & Z Food Additives Co., Ltd. (China)

Aminolabs (Germany)

CellMark AB (Sweden)

Atlantic Chemicals Trading GmbH (Germany)

Direct Food Ingredients Ltd. (UK)

Glanbia Nutritionals (USA)

Green Wave Ingredient (USA)

Prinova Group LLC (USA)

Why buy this Report

This report may help Strategists, Investors, Laboratories, Contract Research Organizations, Biotechnology & Healthcare Companies, Academic Professionals, Drug Approval Authorities, and Other Organizations to –

Identify Market Opportunities
Review and Analyze Global and Regional Markets
Gauge Market Potential for your Products
Identify Competition
Use Market Research for exploring new areas
Acquire Meaningful Guidelines for Strategic Planning
Gear up for Market Entry
Get Actionable Information
Analytics and data presented in each report pertain to several parameters such as –

Global and Regional Market Sizes, Market Shares, Market Trends
Product (Global and Regional) Market Sizes, Market Shares, Market Trends
Technology Trends
Corporate Intelligence
Key Companies By Sales, Brands, Products
Other Strategic Business Affecting Data

Buy now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=905737
Continued…

Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (US) Ph: +44 208 133 9349 (UK)

Contact Info:
Name: NORAH TRENT
Email: Sales@Wiseguyreports.Com
Organization: WISE GUY RESEARCH CONSULTANTS PVT LTD
Address: Pune 411028 , Maharashtra, India
Phone: +1-646-845-9349 / +44 208 133 9349

Source URL: http://marketersmedia.com/lysine-market-2017-global-analysis-opportunities-and-forecast-to-2021/165395

For more information, please visit https://www.wiseguyreports.com/sample-request/905737-lysine-market-research-report

Source: MarketersMedia

Release ID: 165395

Malnutrition Pharmaceutical and Healthcare Pipeline Review H2

WiseGuyReports.com adds “Malnutrition Global Clinical Trials Review, H2, 2016” reports to its database.

Pune, India – January 30, 2017 /MarketersMedia/

Summary
“Malnutrition Global Clinical Trials Review, H2, 2016″ provides an overview of Malnutrition clinical trials scenario. This report provides top line data relating to the clinical trials on Malnutrition. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical Trial Reports are generated using proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/910182-malnutrition-global-clinical-trials-review-h2-2016

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Scope
– The report provides a snapshot of the global clinical trials landscape
– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
– The Report provides enrollment trends for the past five years
– Report provides latest news for the past three months

Reasons to buy
– Assists in formulating key business strategies with regards to investment
– Helps in identifying prominent locations for conducting clinical trials which saves time and cost
– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
– Supports understanding of trials count and enrollment trends by country in global therapeutics market
– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
– Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Content: Key Points
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Five Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Malnutrition to Nutritional Disorders Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Malnutrition to Nutritional Disorders Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Malnutrition Therapeutics Clinical Trials 27
Prominent Drugs 29
Clinical Trial Profile Snapshots 30
Appendix 126
Abbreviations 126
Definitions 126
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/910182-malnutrition-global-clinical-trials-review-h2-2016

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Contact Info:
Name: Norah Trent
Organization: WiseGuy Reports
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune – 411028 Maharashtra, India
Phone: +1-646-845-9349

Source URL: http://marketersmedia.com/malnutrition-pharmaceutical-and-healthcare-pipeline-review-h2/165386

For more information, please visit http://www.wiseguyreports.com

Source: MarketersMedia

Release ID: 165386

Video Event Data Recorder Global Market Share, Size, Trend and Growth 2017-2021

Wiseguyreports.Com Publish New Market Research Report On-“Video Event Data Recorder Global Market Share, Size, Trend and Growth 2017-2021”.

Pune, India – January 30, 2017 /MarketersMedia/

Video Event Data Recorder Market

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/911973-global-video-event-data-recorder-market-research-report-2017

This report studies Video Event Data Recorder in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering
Digital Ally
Octo Telematics
WatchGuard Video
L-3 Mobile-Vision
COBAN Technologies
Omnitracs
Safety Vision
Convoy Technologies

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Video Event Data Recorder in these regions, from 2011 to 2021 (forecast), like
North America
Europe
China
Japan
Southeast Asia
India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
Flash Card
Cloud Data Storage

Split by application, this report focuses on consumption, market share and growth rate of Video Event Data Recorder in each application, can be divided into
Passenger Cars
Commercial Vehicles

Complete Report Details @ https://www.wiseguyreports.com/reports/911973-global-video-event-data-recorder-market-research-report-2017

Table of Contents

Global Video Event Data Recorder Market Research Report 2017
1 Video Event Data Recorder Market Overview
1.1 Product Overview and Scope of Video Event Data Recorder
1.2 Video Event Data Recorder Segment by Type
1.2.1 Global Production Market Share of Video Event Data Recorder by Type in 2015
1.2.2 Flash Card
1.2.3 Cloud Data Storage
1.3 Video Event Data Recorder Segment by Application
1.3.1 Video Event Data Recorder Consumption Market Share by Application in 2015
1.3.2 Passenger Cars
1.3.3 Commercial Vehicles
1.3.4 Application 3
1.4 Video Event Data Recorder Market by Region
1.4.1 North America Status and Prospect (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 China Status and Prospect (2012-2022)
1.4.4 Japan Status and Prospect (2012-2022)
1.4.5 Southeast Asia Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Video Event Data Recorder (2012-2022)

………….

7 Global Video Event Data Recorder Manufacturers Profiles/Analysis
7.1 Digital Ally
7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
7.1.2 Video Event Data Recorder Product Type, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Digital Ally Video Event Data Recorder Production, Revenue, Price and Gross Margin (2015 and 2016)
7.1.4 Main Business/Business Overview
7.2 Octo Telematics
7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
7.2.2 Video Event Data Recorder Product Type, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Octo Telematics Video Event Data Recorder Production, Revenue, Price and Gross Margin (2015 and 2016)
7.2.4 Main Business/Business Overview
7.3 WatchGuard Video
7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
7.3.2 Video Event Data Recorder Product Type, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 WatchGuard Video Video Event Data Recorder Production, Revenue, Price and Gross Margin (2015 and 2016)
7.3.4 Main Business/Business Overview
7.4 L-3 Mobile-Vision
7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
7.4.2 Video Event Data Recorder Product Type, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
..…..Continued

Any Query?, Ask Here @ https://www.wiseguyreports.com/enquiry/911973-global-video-event-data-recorder-market-research-report-2017

Contact Info:
Name: Norah Trent
Organization: WiseGuy Research Consultants Pvt. Ltd.
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune – 411028 Maharashtra, India
Phone: +1-646-845-9349

Source URL: http://marketersmedia.com/video-event-data-recorder-global-market-share-size-trend-and-growth-2017-2021/165369

For more information, please visit http://www.wiseguyreports.com

Source: MarketersMedia

Release ID: 165369

Medical Sensors Market is Growing CAGR of 8% from 2016-2022 due to Increase in Prevalence of Chronic Diseases

Global Medical Sensors Market which is expected to grow at the CAGR of 8% from 2016 to 2022

Pune, India – January 30, 2017 /MarketersMedia/

Market Highlights
Medical sensors are devices which diagnosis a patient’s medical condition as well as monitor the same. These sensors increases the use of medical equipment’s such as life-supporting implants also in monitoring a patient’s vital health signs and other health factors which ultimately improves the quality of care provided to patients by avoiding complications. The Medical Sensors Market is booming due to the increasing aging population which has fueled the development of new and different types of medical equipment’s and has also increased demand for various sensors that are used in medical equipment and patients’ bodies.

On the basis of product type there are pressure sensors that are used in various medical devices such as drug delivery machines, infusion and insulin pumps, respiratory monitoring, blood pressure monitoring equipment and dental instruments. Other medical devices are temperature sensors which are used for monitoring temperature to provide unmatched accuracy and sensitivity in detecting body temperature. Image sensors are used in different types of imaging methods. Accelerometers are used in heart pacemakers and defibrillators, patient monitoring equipment, blood pressure monitors, and other integrated health monitoring equipment. Biosensors are used to diagnose glucose and cholesterol level as well as for testing for drug abuse and infectious diseases. Encoders are found in sports and healthcare equipment and other noncritical medical devices.

Kay Players
• TE Connectivity Corporation (US)
• Murata Manufacturing Co.
• Shimmer (Ireland)
• Merit Medical Systems, Inc. (US)
• Sensirion AG (Switzerland)
• Masimo Corporation (US)
• Mouser Electronics, Inc. (US)
• PreSens Precision Sensing GmbH (Germany)
• Novosense AB (Sweden)
• ST. JUDE MEDICAL (US)
• First Sensor AG
• Medtronic Plc. (Ireland)
• Measurement Specialties Inc. (U.S)
• Honeywell International, Inc. (U.S)
• Smiths Medical (U.K)

Request a Sample Report @ https://marketresearchfuture.com/sample_request/2038

Medical devices are used in various medical appliances including device, cardiovascular monitoring and diagnosis, patient monitoring, surgery/drug delivery system and many home diagnostics medical devices.

Global Medical Sensors Market:
The global medical sensors market has been evaluated to be rapidly growing and is expected to grow further in future. Factors such as increasing prevalence of chronic diseases and latest innovation in technologies will fuel the growth of the market. The global medical sensors market is expected to grow at the CAGR of 8% during in the future.

Regional Analysis:
Depending on geographic region, medical sensors market is segmented into four key regions: North America, Europe, Asia Pacific, and Middle East & Africa. Globally North America is the largest market for Medical sensors as it has the most advanced healthcare technologies along increasing demand for reliable and cost effective products. Europe is the second largest market for medical sensors. Asia Pacific region is expected to be fastest growing region of the medical sensors market due to rising awareness among patients and increasing healthcare expenditure.

Browse Report @ https://marketresearchfuture.com/reports/medical-sensors-market

Segmentation:
Global medical sensors market has been segmented on the basis of product type which comprises of pressure sensors, SQUID, temperature sensors, biosensors, image sensors, accelerometers, encoders and others. On the basis of application; market is segmented into cardiovascular monitoring, patient monitoring, diagnosis, surgical/drug delivery, home and mobile health care and others. On the basis of end-users; market is segmented into hospitals, clinics, home healthcare and others.

Intended Audience
• Medical sensors manufacturers
• Medical sensors suppliers
• CROs/CMOs
• Government Research Laboratories
• Private Research Laboratories
• Research and Development (R&D) Companies
• Market Research and Consulting Service Providers

Related Report
Home Healthcare Market information, by type (products, services, solutions), by application (wound care, patient education, nutrition therapy, monitoring, others) – Forecast to 2022 https://www.marketresearchfuture.com/reports/home-healthcare-market

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Info:
Name: Akash Anand
Email: akash.anand@marketresearchfuture.com
Organization: Market Research Future
Address: Office No. 524/528, Amanora Chambers, Magarpatta Road, Hadapsar Pune
Phone: +1 646 845 9312

Source URL: http://marketersmedia.com/medical-sensors-market-is-growing-cagr-of-8-from-2016-2022-due-to-increase-in-prevalence-of-chronic-diseases/165406

For more information, please visit https://marketresearchfuture.com/reports/medical-sensors-market

Source: MarketersMedia

Release ID: 165406

Varicose Veins Pharmaceutical and Healthcare Pipeline Review H2

WiseGuyReports.com adds “Varicose Veins Global Clinical Trials Review, H2, 2016” reports to its database.

Pune, India – January 30, 2017 /MarketersMedia/

Summary
“Varicose Veins Global Clinical Trials Review, H2, 2016″ provides an overview of Varicose Veins clinical trials scenario. This report provides top line data relating to the clinical trials on Varicose Veins. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical Trial Reports are generated using proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/910189-varicose-veins-global-clinical-trials-review-h2-2016

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Scope
– The report provides a snapshot of the global clinical trials landscape
– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
– The Report provides enrollment trends for the past five years
– Report provides latest news for the past three months

Reasons to buy
– Assists in formulating key business strategies with regards to investment
– Helps in identifying prominent locations for conducting clinical trials which saves time and cost
– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
– Supports understanding of trials count and enrollment trends by country in global therapeutics market
– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
– Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Content: Key Points
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Varicose Veins to Hematological Disorders Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Varicose Veins to Hematological Disorders Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Varicose Veins Therapeutics Clinical Trials 27
Prominent Drugs 29
Clinical Trial Profile Snapshots 30
Appendix 51
Abbreviations 51
Definitions 51
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/910189-varicose-veins-global-clinical-trials-review-h2-2016

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Contact Info:
Name: Norah Trent
Organization: WiseGuy Reports
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune – 411028 Maharashtra, India
Phone: +1-646-845-9349

Source URL: http://marketersmedia.com/varicose-veins-pharmaceutical-and-healthcare-pipeline-review-h2/165409

For more information, please visit http://www.wiseguyreports.com

Source: MarketersMedia

Release ID: 165409

IT Asset Management Software Market: Industry Analysis, Demand, Trend and Global Forecast to 2027

Global IT Asset Management Software Market information research report, by Deployment (on-premise IT asset management software, cloud-based IT asset management software and hybrid IT asset management software), by type (hardware asset management, software asset management) – Global Forecast 2027

Pune, India – January 30, 2017 /MarketersMedia/

Market Scenario:
IT Asset management software refers to those software which are being used to monitor the IT assets in the organization. This software plays very vital role in the cost minimization and excess purchase of IT Assets. It involves the identification and deep collection of information about hardware and software which are being used in the organization and helps in the purchase decision. Currently this market has seen marvelous growth as every organization needs IT products for effective process and this software helps to monitor the IT Assets.

Request a Sample Copy @ https://www.marketresearchfuture.com/sample_request/920

Market Segmentation:
For the better understanding of the report, this market has been segmented on the basis Deployment which includes- on-premise IT asset management software, cloud-based IT asset management software and hybrid IT asset management software. And by types which includes hardware asset management and software asset management.

Key Players of IT Asset Management Software Market:
• ServiceNow, Inc.
• Microsoft Corporation
• BMC Software Inc.
• IBM Corporation
• HP Inc.
• Oracle Corp
• Dell Inc.
• LANDESK Software
• Samanage Ltd.
• Symantec Corp.

Industry News:
• In June 2016, LANDESK Software upgraded the compatibility level to windows 10 and mobile.
• In May 2016, Symantec Corporation announced the encryption to everywhere in order to make software more secure.
• Major companies including Microsoft, IBM, and HP among others offer IT asset management software into their product portfolio.
• Microsoft provides SAM which is Software Asset Management which can be used to assess the strength for the existing infrastructure, process and procedures.
• IBM offers Tivoli Asset Management software which is used for IT and effective management of IT assets life cycle.
• HP provides HPE asset manager which is complete asset portfolio management software and keeps provide features like hardware and software asset management, easy cloud chargeback, centralized contact management among other features.

Access Report Details @ https://www.marketresearchfuture.com/reports/it-asset-management-software-market

Study Objective of IT Asset Management Software:
• To provide detailed analysis of the market structure along with forecast of the various segments and sub-segments of the Global IT Asset Management Software Market.
• To provide insights about factors affecting the market growth.
• To analyze the IT Asset Management Software market based on various factors- price analysis, supply chain analysis, porter’s five force analysis etc.
• To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- North America, Europe, Asia, and Rest of the World (ROW).
• To provide country level analysis of the market with respect to the current market size and future prospective.
• To provide country level analysis of the market for segment, by scale, by type and by deployment and sub-segments.
• To provide strategic profiling of key players in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market.
• To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Global IT Asset Management Software Market.

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Technologies and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Info:
Name: Akash Anand
Organization: Market Research Future
Address: Hadapsar, Pune
Phone: +1 646 845 9312

Source URL: http://marketersmedia.com/it-asset-management-software-market-industry-analysis-demand-trend-and-global-forecast-to-2027/165388

For more information, please visit https://www.marketresearchfuture.com/

Source: MarketersMedia

Release ID: 165388

Hemorrhage Pharmaceutical, Drug and Healthcare Pipeline Review H2

WiseGuyReports.com adds “Hemorrhage Global Clinical Trials Review, H2, 2016” reports to its database.

Pune, India – January 30, 2017 /MarketersMedia/

Summary
“Hemorrhage Global Clinical Trials Review, H2, 2016″ provides an overview of Hemorrhage clinical trials scenario. This report provides top line data relating to the clinical trials on Hemorrhage. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical Trial Reports are generated using proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/910184-hemorrhage-global-clinical-trials-review-h2-2016

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Scope
– The report provides a snapshot of the global clinical trials landscape
– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
– The Report provides enrollment trends for the past five years
– Report provides latest news for the past three months

Reasons to buy
– Assists in formulating key business strategies with regards to investment
– Helps in identifying prominent locations for conducting clinical trials which saves time and cost
– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
– Supports understanding of trials count and enrollment trends by country in global therapeutics market
– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
– Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Content: Key Points
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Five Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Hemorrhage to Hematological Disorders Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Hemorrhage to Hematological Disorders Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Hemorrhage Therapeutics Clinical Trials 27
Prominent Drugs 29
Clinical Trial Profile Snapshots 30
Appendix 327
Abbreviations 327
Definitions 327
Research Methodology 328
Secondary Research 328
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/910184-hemorrhage-global-clinical-trials-review-h2-2016

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Contact Info:
Name: Norah Trent
Organization: WiseGuy Reports
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune – 411028 Maharashtra, India
Phone: +1-646-845-9349

Source URL: http://marketersmedia.com/hemorrhage-pharmaceutical-drug-and-healthcare-pipeline-review-h2/165392

For more information, please visit http://www.wiseguyreports.com

Source: MarketersMedia

Release ID: 165392

Unnatural Amino Acids Market 2017 Global Analysis, Opportunities and Forecast To 2021

Unnatural Amino Acids -Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2021

Pune, India – January 30, 2017 /MarketersMedia/

Unnatural Amino Acids Industry

Description

Wiseguyreports.Com Adds “Unnatural Amino Acids -Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2021” To Its Research Database

Unnatural Amino acids Market research report gives an insight into the different types of Unnatural Amino Acids (ß-Amino Acids, ß-Amino Acid Derivatives, Cyclic Amino Acids & Derivatives, D-Amino Acids, D-Amino Acid Derivatives, DL-Amino Acids, DL-Amino Acid Derivatives, L-Amino Acid Derivatives and Other ) and their application areas such as R&D, Pharmaceutical, Food & Feed, Agrochemicals and Other. The study includes historic, current, and future markets for 2010 -2022 for the global Unnatural Amino Acids market by type and applications. Regional Analysis is covered separately for North America (United States and Canada); Europe (UK, Germany, Switzerland, Italy, The Netherlands, and Rest of Europe); Asia Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia Pacific); and Rest of World. The text is complemented with graphical representations of 293 exhibits. Business profiles of 58 major companies are discussed in the report.

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/905723-unnatural-amino-acids-market-research-report

The report serves as a guide to global Unnatural Amino Acids industry covering more than 500 companies that are engaged in Unnatural Amino Acids R&D, synthesis, discovery, testing and supply of derivatives, products and services. Compilation of Worldwide Patents and Research related to Unnatural Amino Acids market size is also provided. Information related to industrial activity, corporate developments, research trends, product releases, product developments, partnerships, collaborations, and mergers and acquisitions is also covered in the report.

Highlights

Modern drug discovery research is increasingly experimenting with unnatural amino acids, the non‐proteinogenic amino acids, either natural or chemically synthesized. Their unlimited structural diversity and versatile applications are being used as chiral building blocks and molecular scaffolds in building combinatorial libraries. These molecules are powerful ingredients in therapeutic peptidomimetics and are used as molecular probes which can assimilate the biological systems better. They show improved in vivo stability, better potency, oral absorption, tissue distribution, and better and selective responses. Unnatural amino acids are increasingly being used to alter the peptides tertiary structure. Drug candidates with side chain modifications meet and match their biological targets.

The pharmaceutical industry accounts for almost 80% of chiral market revenues. Despite the fact that chiral drugs have been in use much before the arrival of modern medicine, it is only now that chiral drugs in the pharmaceutical industry has gained so much attention. This is largely due to the understanding that enantiomers often show different bioactivity and metabolic fates. In addition there is also a commercial reason where pharmaceutical companies have the chance to extend patent coverage after expiry of patents on racemic drugs. This can take place through the development of the chiral switch enantiomers with suitable bioactivity. Unnatural Amino Acids market is a rapidly growing market in the intermediates sector. Majority of the products utilizing these compounds are pharmaceutical intermediates (β ‐ Lactam Antibiotics). Asia ‐ Pacific region is acquiring lead position in global pharmaceuticals market with the balance gradually shifting from the US and Europe to Asia ‐ Pacific. In principle, an unnatural amino acid can be produced by procedures such as replacement of hydrogen by fluorine in a ring structure, or phenyl by another resonant ring system, or one kind of heterocyclic ring by another one, or a remnant from the framework of an amino acid by another remnant of one that is analogous in shape and size.

Practically all the advantageous amino acid analogues have earlier existed as close structural isomers of amino acids that occur naturally. So far, no efficient analogs of proline, glutamic acid, aspartic acid, alanine, threonine, cysteine, serine or glycine have been accounted for. Probably, the biological sites that are involved in these amino acids are governed by particular size and shape of molecule when compared to amino acids of larger size. Some of the alterations that are performed for the production of anti ‐ metabolites from the larger sized amino acids are not tenable with smaller sized amino acids. This is because the resultant compounds lack appreciable stability as in the case of fluoroglycine or substitution of sulfur for ‐ CH2 within the molecular framework of glutamic acid or threonine. In this regard, the non ‐ existence of proline analog is intriguing, though the occurrence of azetidine ‐ 2 ‐ carboxylic acid is worth mentioning. Most of the amino acid analogues could be conceived as anti ‐ tumor, antiviral or antimicrobial. The amino acid analogues are regularly subjected to screening to find the possibility of anti metabolite activity to counteract bacteria. These experiments are all documented in detail and are useful for those who want to study the effect of analogues on proliferating bacteria. Unnatural Amino Acids market is a rapidly growing market in the intermediates sector. Majority of the products utilizing these compounds are pharmaceutical intermediates (β ‐ Lactam Antibiotics).

Exclusive 25 % flat discount (Offer valid till 31st March 2017) @ https://www.wiseguyreports.com/check-discount/905723-unnatural-amino-acids-market-research-report

Key Players

AbbVie, Inc. (USA)

ACS Dobfar SpA (Italy)

Æterna Zentaris, Inc. (Canada)

Ajinomoto Co., Inc. (Japan)

Amatek Chemical Co., Ltd. (Hong Kong)

AminoLogics Co. Ltd. (South Korea)

AnaSpec, Inc. (USA)

Aspen Pharmacare Holdings Ltd. (South Africa)

AstraZeneca plc (UK)

Bajaj Healthcare Ltd. (India)

BASF SE (Germany)

Bayer CropScience AG (Germany)

Biological E Ltd. (India)

Biovet SA (Spain)

Central Life Sciences (USA)

Corden Pharma International GmbH (Germany)

CSPC Pharmaceutical Group Limited (Hong Kong)

C-TRI Co., Ltd. (South Korea)

Divis Laboratories Ltd. (India)

Donboo Amino Acid Co., Ltd. (China)

DSM Sinochem Pharmaceuticals (Singapore)

EMD Millipore (USA)

EMD Serono, Inc. (USA)

Enzo Life Sciences, Inc. (USA)

Evonik Industries AG (Germany)

GlaxoSmithKline plc (UK)

Hanmi Pharmaceutical Co., Ltd. (South Korea)

Harbin Pharmaceutical Group Co., Ltd. (China)

Hovid Berhad (Malaysia)

IRIS Biotech GmbH (Germany)

Kyowa Hakko Bio Co., Ltd. (Japan)

Lek d.d. (Slovenia)

Lunan Pharmaceutical Group Corporation (China)

Lupin Pharmaceuticals, Inc. (USA)

Mimotopes Pty. Ltd. (Australia)

MP Biomedicals, LLC (USA)

Nagase & Co., Ltd. (Japan)

Norbrook Laboratories Ltd. (UK)

Novartis AG (Switzerland)

Orchid Chemicals & Pharmaceuticals Ltd. (India)

Pfizer, Inc. (USA)

PolyPeptide Group (The) (Denmark)

Ranbaxy Laboratories Ltd. (India)

Sandoz International GmbH (Germany)

Sanofi SA (France)

Sekisui Medical Co., Ltd. (Japan)

Shanghai Hanhong Chemical Co., Ltd. (China)

Shanghai HC Biotech Co., Ltd. (China)

Shanghai PanQi Biochem Tech Co., Ltd. (China)

Sigma-Aldrich Co. LLC (USA)

Tocris Bioscience (USA)

Topsun International Group Co., Ltd. (China)

Unibiochem Co., Ltd. (China)

United Laboratories International Holdings Limited (The) (Hong Kong)

Venus Remedies Ltd. (India)

WR Grace (USA)

Xeno Pharmaceuticals Phils, Inc. (Philippines)

Zhangjiagang Huachang Pharmaceutical Co., Ltd. (China)

Buy now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=905723

Continued…

Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (US) Ph: +44 208 133 9349 (UK)

Contact Info:
Name: NORAH TRENT
Email: Sales@Wiseguyreports.Com
Organization: WISE GUY RESEARCH CONSULTANTS PVT LTD
Address: Pune 411028 , Maharashtra, India
Phone: +1-646-845-9349 / +44 208 133 9349

Source URL: http://marketersmedia.com/unnatural-amino-acids-market-2017-global-analysis-opportunities-and-forecast-to-2021/165405

For more information, please visit https://www.wiseguyreports.com/sample-request/905723-unnatural-amino-acids-market-research-report

Source: MarketersMedia

Release ID: 165405